SFCM
FULC icon

Seven Fleet Capital Management’s Fulcrum Therapeutics FULC Stock Holding History

Seven Fleet Capital Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.2K Sell
18,089
-20,011
-53% -$122K 0.01% 95
2026
Q1 		$292K Buy
+38,100
New +$353K 0.09% 97

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Seven Fleet Capital Management's FULC Position: Q2 2026 in Review

Seven Fleet Capital Management reduced its Fulcrum Therapeutics (FULC) stake by 53% in Q2 2026, selling an estimated $122K and leaving 18,089 shares worth $66.2K. The position accounts for 0.01% of the portfolio, ranked #95.

Seven Fleet Capital Management first reported a position in FULC in Q1 2026 and has held it in 2 quarters since. The position peaked at $292K in Q1 2026. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Seven Fleet Capital Management held 18,089 shares of Fulcrum Therapeutics worth $66.2K as of Q2 2026.
  • Seven Fleet Capital Management sold 20,011 Fulcrum Therapeutics shares in Q2 2026, an estimated $122K.
  • Fulcrum Therapeutics made up 0.01% of Seven Fleet Capital Management's portfolio in Q2 2026, its #95 holding.
  • Seven Fleet Capital Management first reported a position in Fulcrum Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Seven Fleet Capital Management's Fulcrum Therapeutics position peaked at $292K in Q1 2026.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.